Some courses have a planned end
Treatment schedules depend on the cancer, the purpose of treatment, the medicines or radiotherapy used, and how the person is coping. Some treatments are given for a set number of cycles or visits. Others continue while they are helpful and tolerable, sometimes with a change to maintenance treatment.
Completing a planned course is different from stopping because a cancer has progressed. A finite course does not automatically become more effective if extra cycles are added.
More treatment can bring more harm
Healthy tissues can be affected as well as cancer cells. Some side effects become more troublesome with repeated treatment, while others depend on the particular medicine or area treated.
This is not a rule that additional treatment is always harmful or never worthwhile. It means that an extension needs its own evidence and a reason that fits the person's circumstances. Absolute benefit can help put a proposed gain into perspective.
A break is not always a failure
Rest periods may be part of the original schedule. An unplanned pause or dose adjustment may also be needed to allow recovery or investigate a problem. That decision is not identical to choosing the total length of a course.
The existing article on delays, pauses and treatment adjustments explains those situations separately. Do not skip doses or extend a course yourself.
What should I ask when a course finishes?
Ask what the treatment was intended to achieve, why this duration was chosen, and what evidence there is for giving more. Find out what happens next: further treatment, monitoring, rehabilitation or another form of support.
If ongoing treatment is proposed, ask when benefit and side effects will be reassessed. These discussions are part of informed consent, not a sign that you are being difficult.
General information only. Your own team should explain the dose, duration and review plan for your treatment.
